Mumbai: Godrej Agrovet Limited reported a mix bag of results with its revenues rising 9.3% to ₹2,333 crore in Q4 FY26 from ₹ 2,134 crore from the same period last year. Though the company’s net profit rose 48.1% to ₹105 crore in the quarter, the company’s EBITDA has declined 5.3% year on year due to operational pressures and margin contraction.
Along with this, the company’s board has recommended a final dividend of ₹11 per share for the financial year.
Animal Feed: The Growth Engine
The company’s animal feed business remains the largest contributor to its topline, benefitting from rising demand for animal protein. The segment has recorded a massive 24% YoY volume growth in cattle feed during the quarter, outperforming the industry average.
Astec LifeSciences: The EBTIDA Turnaround
After months of underperformance, Godrej Agrovet’s agrochemical active ingredients arm- Astec Lifesciences, has achieved EBITDA break-even, with revenues rising 32.7% year on year, thanks to higher volumes in its enterprise and CDMO (Contract Development and Manufacturing) businesses.
Board approves financial results
The company’s Board of Directors have approved the audited results, and the final dividend is subject to shareholders approval at the company’s upcoming AGM on August 5.
Shares of Godrej Agrovet have risen by 5% over the last month.
